Hammerhead-type FXR agonists induce an eRNA FincoR that ameliorates nonalcoholic steatohepatitis in mice
J. Chen, R. Wang, F. Xiong, H. Sun, B. Kemper, W. Li, J. Kemper
This study identifies a novel FXR-induced eRNA, FincoR, which mediates the therapeutic effects of hammerhead-type FXR agonists in NASH mice.
bioRxiv · Nov 20, 2023 · PreprintPhysiology